Archive - Novoic Newsletter

New

Patient Recruitment Challenges and Solutions for Alzheimer's Disease Clinical Trials

Recruiting patients with Alzheimer's disease (AD) for clinical trials presents a multitude of significant challenges. Alzheimer's is a complex…

Aug 29 •

Harnessing the Power of New Infusion Treatments for Alzheimer’s Disease and Novoic’s Storyteller for Early Alzheimer's Disease Prediction

Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide, causing cognitive decline, memory loss, and…

Aug 4 •

July 2023

The importance of an early Alzheimer's diagnosis

In this blog post Chris Williams, epidemiologist and founder of Tiggo Care, explains why it’s important to diagnose Alzheimer's early for the benefit of…

Jul 17

December 2022

Publication overview

Prior evidence has demonstrated subtle cognitive changes in the earliest stages of Alzheimer’s disease, in the domains of episodic memory, semantic…

Dec 1, 2022

November 2022

Clinical trials across the US and the UK demonstrate first early detection of Alzheimer’s disease with AI-based speech analysis

Released October 17, 2022. Results from two clinical trials published today in the scientific journal Brain Communications provide evidence that very…

Nov 27, 2022

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts